Explore groundbreaking studies, reviews, and discoveries in ubiquitination pathways
Discover how the first-in-class DOT1L PROTAC degrader MS2133 could revolutionize treatment for MLL-rearranged leukemia by completely eliminating the cancer-causing protein.